Imugene Ltd
IMU
Company Profile
Business description
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its product includes HER-Vaxx,PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being the Research and Development of oncolytic immunotherapies.
Contact
4-6 Bligh Street
Suite 12.01, Level 12
Sydney NSW 2000
AUSSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
5
Stocks News & Analysis
stocks
CSL earnings preview: What to look for in ASX200 heavyweight's results
The ASX 200's third biggest company reports earnings on Tuesday. Here's what Morningstar's CSL analyst Shane Ponraj will be looking out for.
stocks
After earnings, is Alphabet stock a buy, a sell, or fairly valued?
With increased revenue and steady infrastructure investment, here’s what we think of Alphabet stock.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,990.70 | 104.20 | 1.32% |
| CAC 40 | 7,269.71 | 22.26 | 0.31% |
| DAX 40 | 17,722.88 | 42.48 | 0.24% |
| Dow JONES (US) | 39,497.54 | 51.05 | 0.13% |
| FTSE 100 | 8,168.10 | 23.13 | 0.28% |
| HKSE | 17,090.23 | 198.40 | 1.17% |
| NASDAQ | 16,745.30 | 85.28 | 0.51% |
| Nikkei 225 | 35,025.00 | 193.85 | 0.56% |
| NZX 50 Index | 12,243.46 | 13.82 | -0.11% |
| S&P 500 | 5,344.16 | 24.85 | 0.47% |
| S&P/ASX 200 | 7,777.70 | 95.70 | 1.25% |
| SSE Composite Index | 2,862.19 | 7.71 | -0.27% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| AMP Ltd AMP | 1.29 | 0.01 | 0.78% |
| Red 5 Ltd RED | 0.36 | 0.01 | 2.90% |
| Pilbara Minerals Ltd PLS | 3.07 | 0.09 | 3.02% |
| South32 Ltd S32 | 2.94 | 0.11 | 3.89% |
| Droneshield Ltd DRO | 1.09 | 0.08 | 7.39% |
| Core Lithium Ltd CXO | 0.10 | 0.00 | 3.23% |
| Mirvac Group MGR | 1.97 | 0.05 | 2.60% |
| Zip Co Ltd ZIP | 1.76 | 0.04 | 2.33% |
| Telstra Group Ltd TLS | 3.84 | 0.01 | 0.26% |
| Imugene Ltd IMU | 0.06 | 0.00 | 5.77% |